Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Impact of a Lung Cancer Screening Information Film on Informed Decision-making: A Randomized Trial.

Ruparel M, Quaife SL, Ghimire B, Dickson JL, Bhowmik A, Navani N, Baldwin DR, Duffy S, Waller J, Janes SM.

Ann Am Thorac Soc. 2019 Jun;16(6):744-751. doi: 10.1513/AnnalsATS.201811-841OC.

PMID:
31082267
2.

A pilot study exploring the relationship between wellness and physical fitness: an examination into autonomic health.

Oliver MD, Morton AL, Baldwin DR, Datta S.

J Am Coll Health. 2019 Apr 8:1-8. doi: 10.1080/07448481.2019.1596919. [Epub ahead of print]

PMID:
30958733
3.

Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial.

Bayman N, Appel W, Ashcroft L, Baldwin DR, Bates A, Darlison L, Edwards JG, Ezhil V, Gilligan D, Hatton M, Jegannathen A, Mansy T, Peake MD, Pemberton L, Rintoul RC, Snee M, Ryder WD, Taylor P, Faivre-Finn C.

J Clin Oncol. 2019 May 10;37(14):1200-1208. doi: 10.1200/JCO.18.01678. Epub 2019 Mar 28.

PMID:
30920878
4.

The relationship between sleep and autonomic health.

Oliver MD, Baldwin DR, Datta S.

J Am Coll Health. 2019 Mar 11:1-7. doi: 10.1080/07448481.2019.1583652. [Epub ahead of print]

PMID:
30856085
5.

Lung cancer screening - gaining consensus on next steps - proceedings of a closed workshop in the UK.

Moffat J, Hiom S, Kumar HS, Baldwin DR.

Lung Cancer. 2018 Nov;125:121-127. doi: 10.1016/j.lungcan.2018.07.029. Epub 2018 Jul 21. Review.

PMID:
30429009
6.

ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe.

Rich AL, Baldwin DR, Beckett P, Berghmans T, Boyd J, Faivre-Finn C, Galateau-Salle F, Gamarra F, Grigoriu B, Hansen NG, Hardavella G, Jakobsen E, Jovanovic D, Konsoulova A, Massard G, McPhelim J, Meert AP, Milroy R, Mutti L, Paesmans M, Peake MD, Putora PM, de Ruysscher DKM, Sculier JP, Scherpereel A, Subotic DR, Van Schil P, Blum TG.

Eur Respir J. 2018 Dec 20;52(6). pii: 1800610. doi: 10.1183/13993003.00610-2018. Print 2018 Dec.

PMID:
30361252
7.

Factors influencing treatment selection and 30-day mortality after chemotherapy for people with small-cell lung cancer: An analysis of national audit data.

Jones GS, McKeever TM, Hubbard RB, Khakwani A, Baldwin DR.

Eur J Cancer. 2018 Nov;103:176-183. doi: 10.1016/j.ejca.2018.07.133. Epub 2018 Sep 24.

PMID:
30261439
8.

Lung cancer in the UK: addressing geographical inequality and late diagnosis.

Hiom SC, Kumar HS, Swanton C, Baldwin DR, Peake MD.

Lancet Oncol. 2018 Aug;19(8):1015-1017. doi: 10.1016/S1470-2045(18)30496-0. No abstract available.

PMID:
30102211
9.

The continuum of screening and early detection, awareness and faster diagnosis of lung cancer.

Peake MD, Navani N, Baldwin DR.

Thorax. 2018 Dec;73(12):1097-1098. doi: 10.1136/thoraxjnl-2018-212189. Epub 2018 Aug 10. No abstract available.

PMID:
30097536
10.

Patient selection for future lung cancer computed tomography screening programmes: lessons learnt post National Lung Cancer Screening Trial.

Field JK, Duffy SW, Baldwin DR.

Transl Lung Cancer Res. 2018 Apr;7(Suppl 2):S114-S116. doi: 10.21037/tlcr.2018.03.12. No abstract available.

11.

EUPS-argues that lung cancer screening should be implemented in 18 months.

Field JK, Baldwin DR, Devaraj A, Oudkerk M.

Br J Radiol. 2018 Oct;91(1090):20180243. doi: 10.1259/bjr.20180243. Epub 2018 May 24.

PMID:
29722546
12.

Recent advances in the management of lung cancer.

Jones GS, Baldwin DR.

Clin Med (Lond). 2018 Apr 1;18(Suppl 2):s41-s46. doi: 10.7861/clinmedicine.18-2-s41.

13.

Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients.

Møller H, Coupland VH, Tataru D, Peake MD, Mellemgaard A, Round T, Baldwin DR, Callister MEJ, Jakobsen E, Vedsted P, Sullivan R, Spicer J.

Thorax. 2018 Jun;73(6):530-537. doi: 10.1136/thoraxjnl-2017-210710. Epub 2018 Mar 6.

14.

Low-dose CT for lung cancer screening - Authors' reply.

Field JK, Heuvelmans MA, Devaraj A, Heussel CP, Baldwin DR, Vliegenthart R, Duffy SW, Oudkerk M.

Lancet Oncol. 2018 Mar;19(3):e135-e136. doi: 10.1016/S1470-2045(18)30122-0. No abstract available.

PMID:
29508758
15.

An examination of college student wellness: A research and liberal arts perspective.

Baldwin DR, Towler K, Oliver MD 2nd, Datta S.

Health Psychol Open. 2017 Aug 2;4(2):2055102917719563. doi: 10.1177/2055102917719563. eCollection 2017 Jul-Dec.

16.

Low dose CT screening for lung cancer.

Baldwin DR, Ten Haaf K, Rawlinson J, Callister MEJ.

BMJ. 2017 Dec 28;359:j5742. doi: 10.1136/bmj.j5742. No abstract available.

PMID:
29284594
17.

European position statement on lung cancer screening.

Oudkerk M, Devaraj A, Vliegenthart R, Henzler T, Prosch H, Heussel CP, Bastarrika G, Sverzellati N, Mascalchi M, Delorme S, Baldwin DR, Callister ME, Becker N, Heuvelmans MA, Rzyman W, Infante MV, Pastorino U, Pedersen JH, Paci E, Duffy SW, de Koning H, Field JK.

Lancet Oncol. 2017 Dec;18(12):e754-e766. doi: 10.1016/S1470-2045(17)30861-6. Review.

PMID:
29208441
18.

Treatment recommendations for stage I non-small cell lung cancer: does patient preference matter?

Powell HA, Baldwin DR.

Ann Transl Med. 2017 Oct;5(20):411. doi: 10.21037/atm.2017.08.01. No abstract available.

19.

Impact of radiographer immediate reporting of chest X-rays from general practice on the lung cancer pathway (radioX): study protocol for a randomised control trial.

Woznitza N, Devaraj A, Janes SM, Duffy SW, Bhowmik A, Rowe S, Piper K, Maughn S, Baldwin DR.

Trials. 2017 Nov 6;18(1):521. doi: 10.1186/s13063-017-2268-x.

20.

A sympathetic nervous system evaluation of obesity stigma.

Oliver MD, Datta S, Baldwin DR.

PLoS One. 2017 Oct 30;12(10):e0185703. doi: 10.1371/journal.pone.0185703. eCollection 2017.

21.

Wellness among African-American and Caucasian students attending a predominantly White institution.

Oliver MD 2nd, Datta S, Baldwin DR.

J Health Psychol. 2017 Feb 1:1359105317694484. doi: 10.1177/1359105317694484. [Epub ahead of print]

22.

Physician Assessment of Pretest Probability of Malignancy and Adherence to Guidelines for Pulmonary Nodule Evaluation.

Baldwin DR, Callister MEJ.

Chest. 2017 Aug;152(2):447-448. doi: 10.1016/j.chest.2017.03.045. No abstract available.

PMID:
28797389
23.

Lung cancer screening-low dose CT for lung cancer screening: recent trial results and next steps.

O'Dowd EL, Baldwin DR.

Br J Radiol. 2018 Oct;91(1090):20170460. doi: 10.1259/bjr.20170460. Epub 2017 Oct 17. Review.

PMID:
28749712
24.

Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial.

Brain K, Carter B, Lifford KJ, Burke O, Devaraj A, Baldwin DR, Duffy S, Field JK.

Thorax. 2017 Oct;72(10):912-918. doi: 10.1136/thoraxjnl-2016-209690. Epub 2017 Jul 14.

25.

The impact of trained radiographers as concurrent readers on performance and reading time of experienced radiologists in the UK Lung Cancer Screening (UKLS) trial.

Nair A, Screaton NJ, Holemans JA, Jones D, Clements L, Barton B, Gartland N, Duffy SW, Baldwin DR, Field JK, Hansell DM, Devaraj A.

Eur Radiol. 2018 Jan;28(1):226-234. doi: 10.1007/s00330-017-4903-z. Epub 2017 Jun 22.

26.

Lung cancer in symptomatic patients presenting in primary care: a systematic review of risk prediction tools.

Schmidt-Hansen M, Berendse S, Hamilton W, Baldwin DR.

Br J Gen Pract. 2017 Jun;67(659):e396-e404. doi: 10.3399/bjgp17X690917. Epub 2017 May 8. Review.

27.

Socioeconomic position and delays in lung cancer diagnosis: should we target the more deprived?

Baldwin DR.

Thorax. 2017 May;72(5):393-395. doi: 10.1136/thoraxjnl-2016-209591. Epub 2016 Dec 19. No abstract available.

PMID:
27993958
29.

Optimum low dose CT screening interval for lung cancer: the answer from NELSON?

Baldwin DR, Duffy SW, Devaraj A, Field JK.

Thorax. 2017 Jan;72(1):6-7. doi: 10.1136/thoraxjnl-2016-209011. Epub 2016 Oct 21. No abstract available.

PMID:
27974632
30.
31.

Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data.

Walker AJ, Baldwin DR, Card TR, Powell HA, Hubbard RB, Grainge MJ.

Br J Cancer. 2017 Mar 14;116(6):e1. doi: 10.1038/bjc.2016.364. Epub 2016 Nov 1. No abstract available.

32.

Implementation planning for lung cancer screening: five major challenges.

Field JK, Duffy SW, Devaraj A, Baldwin DR.

Lancet Respir Med. 2016 Sep;4(9):685-687. doi: 10.1016/S2213-2600(16)30233-8. No abstract available.

PMID:
27599242
33.

Place of Death in Patients with Lung Cancer: A Retrospective Cohort Study from 2004-2013.

O'Dowd EL, McKeever TM, Baldwin DR, Hubbard RB.

PLoS One. 2016 Aug 23;11(8):e0161399. doi: 10.1371/journal.pone.0161399. eCollection 2016.

34.

What is the Optimum Screening Strategy for the Early Detection of Lung Cancer.

Baldwin DR, Callister ME.

Clin Oncol (R Coll Radiol). 2016 Nov;28(11):672-681. doi: 10.1016/j.clon.2016.08.001. Epub 2016 Aug 17. Review.

PMID:
27544425
35.

Comparing the performance of trained radiographers against experienced radiologists in the UK lung cancer screening (UKLS) trial.

Nair A, Gartland N, Barton B, Jones D, Clements L, Screaton NJ, Holemans JA, Duffy SW, Field JK, Baldwin DR, Hansell DM, Devaraj A.

Br J Radiol. 2016 Oct;89(1066):20160301. doi: 10.1259/bjr.20160301. Epub 2016 Jul 27.

36.

Defining a standard set of patient-centred outcomes for lung cancer.

Mak KS, van Bommel AC, Stowell C, Abrahm JL, Baker M, Baldotto CS, Baldwin DR, Borthwick D, Carbone DP, Chen AB, Fox J, Haswell T, Koczywas M, Kozower BD, Mehran RJ, Schramel FM, Senan S, Stirling RG, van Meerbeeck JP, Wouters MW, Peake MD; Lung Cancer Working Group of ICHOM.

Eur Respir J. 2016 Sep;48(3):852-60. doi: 10.1183/13993003.02049-2015. Epub 2016 Jul 7.

37.

Lung cancer risk in new pulmonary nodules: implications for CT screening and nodule management.

Baldwin DR, Devaraj A.

Lancet Oncol. 2016 Jul;17(7):849-850. doi: 10.1016/S1470-2045(16)30134-6. Epub 2016 Jun 6. No abstract available.

PMID:
27283864
38.

Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data.

Walker AJ, Baldwin DR, Card TR, Powell HA, Hubbard RB, Grainge MJ.

Br J Cancer. 2016 Jun 28;115(1):115-21. doi: 10.1038/bjc.2016.143. Epub 2016 Jun 2. Erratum in: Br J Cancer. 2017 Mar 14;116(6):e1.

39.

The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.

Field JK, Duffy SW, Baldwin DR, Brain KE, Devaraj A, Eisen T, Green BA, Holemans JA, Kavanagh T, Kerr KM, Ledson M, Lifford KJ, McRonald FE, Nair A, Page RD, Parmar MK, Rintoul RC, Screaton N, Wald NJ, Weller D, Whynes DK, Williamson PR, Yadegarfar G, Hansell DM.

Health Technol Assess. 2016 May;20(40):1-146. doi: 10.3310/hta20400.

40.

Management of pulmonary nodules according to the 2015 British Thoracic Society guidelines. Key messages for clinical practice.

Baldwin DR.

Pol Arch Med Wewn. 2016 Apr 26;126(4):262-74. doi: 10.20452/pamw.3379. Epub 2016 Apr 26. Review.

41.

The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and 'hard-to-reach' patients.

Quaife SL, Ruparel M, Beeken RJ, McEwen A, Isitt J, Nolan G, Sennett K, Baldwin DR, Duffy SW, Janes SM, Wardle J.

BMC Cancer. 2016 Apr 20;16:281. doi: 10.1186/s12885-016-2316-z.

42.

Predicting death from surgery for lung cancer: A comparison of two scoring systems in two European countries.

O'Dowd EL, Lüchtenborg M, Baldwin DR, McKeever TM, Powell HA, Møller H, Jakobsen E, Hubbard RB.

Lung Cancer. 2016 May;95:88-93. doi: 10.1016/j.lungcan.2016.03.002. Epub 2016 Mar 15.

PMID:
27040857
43.

Pulmonary nodules and CT screening: the past, present and future.

Ruparel M, Quaife SL, Navani N, Wardle J, Janes SM, Baldwin DR.

Thorax. 2016 Apr;71(4):367-75. doi: 10.1136/thoraxjnl-2015-208107. Epub 2016 Feb 26. Review.

44.

Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention.

Bayman N, Ardron D, Ashcroft L, Baldwin DR, Booton R, Darlison L, Edwards JG, Lang-Lazdunski L, Lester JF, Peake M, Rintoul RC, Snee M, Taylor P, Lunt C, Faivre-Finn C.

BMJ Open. 2016 Jan 27;6(1):e010589. doi: 10.1136/bmjopen-2015-010589.

45.

Return of the pulmonary nodule: the radiologist's key role in implementing the 2015 BTS guidelines on the investigation and management of pulmonary nodules.

Graham RN, Baldwin DR, Callister ME, Gleeson FV.

Br J Radiol. 2016;89(1059):20150776. doi: 10.1259/bjr.20150776. Epub 2016 Jan 19.

46.

How should pulmonary nodules be optimally investigated and managed?

Callister ME, Baldwin DR.

Lung Cancer. 2016 Jan;91:48-55. doi: 10.1016/j.lungcan.2015.10.018. Epub 2015 Oct 27. Review.

PMID:
26711934
47.

CT screening for lung cancer: Is the evidence strong enough?

Field JK, Devaraj A, Duffy SW, Baldwin DR.

Lung Cancer. 2016 Jan;91:29-35. doi: 10.1016/j.lungcan.2015.11.003. Epub 2015 Nov 30. Review.

PMID:
26711931
48.

UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.

Field JK, Duffy SW, Baldwin DR, Whynes DK, Devaraj A, Brain KE, Eisen T, Gosney J, Green BA, Holemans JA, Kavanagh T, Kerr KM, Ledson M, Lifford KJ, McRonald FE, Nair A, Page RD, Parmar MK, Rassl DM, Rintoul RC, Screaton NJ, Wald NJ, Weller D, Williamson PR, Yadegarfar G, Hansell DM.

Thorax. 2016 Feb;71(2):161-70. doi: 10.1136/thoraxjnl-2015-207140. Epub 2015 Dec 8.

49.

Development of Guidelines for the Management of Pulmonary Nodules: Toward Better Implementation.

Baldwin DR.

Chest. 2015 Dec;148(6):1365-1367. doi: 10.1378/chest.15-1906. No abstract available.

50.

Pulmonary nodules again? The 2015 British Thoracic Society guidelines on the investigation and management of pulmonary nodules.

Baldwin DR, Callister ME, Graham R, Gleeson F; members of the Guideline Development Group.

Clin Radiol. 2016 Jan;71(1):18-22. doi: 10.1016/j.crad.2015.10.017. Epub 2015 Nov 20. No abstract available.

PMID:
26607915

Supplemental Content

Loading ...
Support Center